Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 311.2B | 268.5B | 291.2B | 269.2B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 16.9B | 17.7B | 17.0B | 17.7B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 64.0B | 62.8B | 60.5B | 55.9B |
| Other income expense | 2.8B | 7.4B | 6.2B | 5.3B |
| Pretax income | 60.0B | 58.1B | 59.7B | 59.7B |
| Tax provision | 12.5B | 14.0B | 17.9B | 17.6B |
| Net income | 47.6B | 44.1B | 41.8B | 42.1B |
| Basic EPS | — | 14 | 13.1 | 13.4 |
| Diluted EPS | — | 13.9 | 13 | 13.3 |
| Basic average shares | — | 1.6B | 1.6B | 1.6B |
| Diluted average shares | — | 1.6B | 1.6B | 1.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -23.4B | -21.8B | -20.9B | -20.7B |
| Preferred stock dividends | — | — | — | — |